anmelden
Swiss All Share Index
20.155,30
PKT
+118,84
PKT
+0,59
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.01.17 | UBS Buy | UBS AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | Nestlé buy | UBS AG | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Zurich Insurance Outperform | BNP PARIBAS | |
| 25.01.17 | Novartis Outperform | Bernstein Research | |
| 25.01.17 | Novartis buy | Baader Bank | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | UBS buy | Baader Bank | |
| 24.01.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.17 | UBS buy | HSBC | |
| 23.01.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.01.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 23.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 23.01.17 | UBS Equal-Weight | Morgan Stanley | |
| 23.01.17 | UBS overweight | Morgan Stanley | |
| 23.01.17 | Nestlé overweight | Barclays Capital | |
| 20.01.17 | UBS Hold | Deutsche Bank AG | |
| 20.01.17 | Swiss Re Hold | Deutsche Bank AG | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.01.17 | Holcim buy | Deutsche Bank AG | |
| 18.01.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 18.01.17 | UBS buy | UBS AG | |
| 18.01.17 | Swiss Re Underperform | Jefferies & Company Inc. | |
| 17.01.17 | Nestlé buy | Deutsche Bank AG | |
| 17.01.17 | Givaudan buy | Deutsche Bank AG | |
| 16.01.17 | Swiss Re Underperform | Credit Suisse Group | |
| 16.01.17 | Nestlé buy | UBS AG | |
| 16.01.17 | Zurich Insurance Outperform | Credit Suisse Group | |
| 16.01.17 | Swiss Re Sell | UBS AG | |
| 16.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 16.01.17 | UBS buy | Goldman Sachs Group Inc. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 13.01.17 | UBS Underperform | Macquarie Research |